Log In
BCIQ
Print this Print this
 

Phosphodiesterase-5 (PDE-5)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Phosphodiesterase-5 (PDE-5)

BCIQ
Print ChartPrint this
Marketed, 5 Marketed, 2 Approved, 1 Phase IV, 1 Phase III, 1 Phase III, 1 Phase II, 1 Phase II, 1 Phase II, 1 Phase II, 3 Phase I/II, 1 Pilot, 1 IND, 1 Preclinical, 1 Preclinical, 1 Preclinical, 1 Discovery, 1 Discovery, 1
Phase of DevelopmentDiscoveryPreclinicalINDPilotPhase I/IIPhase IIPhase IIIPhase IVApprovedMarketed
Cancer

-

1

-

-

-

-

-

-

-

-

Cardiovascular

1

1

-

-

1

3

-

-

-

2

Genitourinary

1

1

1

1

-

1

1

-

1

5

Inflammation

-

-

-

-

-

1

-

-

-

-

Musculoskeletal

-

-

-

-

-

-

1

-

-

-

Ophthalmic

-

-

-

-

-

-

-

1

-

-

Renal

-

-

-

-

-

1

-

-

-

-




 Products Targeting Phosphodiesterase-5 (PDE-5)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

7

$160,361.0M

$160,035.0M

$429.2M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today